Canonical: https://ownershiptrace.com/13f/companies/4339

# Who owns ANAPTYSBIO, INC (ANAB)? Elite investor 13F holders

5 tracked elite investors reported holding ANAPTYSBIO, INC as of 2026-06-30, including D.E. Shaw, Renaissance Technologies LLC, Irenic Capital, Gotham Asset Management, Ancora Advisors / Ancora Holdings. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

5 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

AnaptysBio, Inc., a clinical-stage biotechnology company, focuses in delivering immunology therapeutics for autoimmune and inflammatory diseases in the United States. The company's products include Rosnilimab, a selective pathogenic T cell deplete which completed a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis; ANB033, a CD122 antagonist, which is in a Phase 1b trial…

## Reported holders and securities, including exits (up to 20)

| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|  --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| [D.E. Shaw](https://ownershiptrace.com/13f/investors/98) | ANAPTYSBIO INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 36427456.00 USD | 539666.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1009207/0001104659-26-097217-index.html) |
| [Renaissance Technologies LLC](https://ownershiptrace.com/13f/investors/63) | ANAPTYSBIO INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 3935250.00 USD | 58300.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1037389/0001037389-26-000059-index.html) |
| [Irenic Capital](https://ownershiptrace.com/13f/investors/99) | ANAPTYSBIO INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 4755173.00 USD | 70447.000000 | Shares | buy | [Original filing](https://www.sec.gov/Archives/edgar/data/1929389/0001929389-26-000007-index.html) |
| [Gotham Asset Management](https://ownershiptrace.com/13f/investors/94672) | ANAPTYSBIO INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 424710.00 USD | 6292.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1510387/0001398344-26-014644-index.html) |
| [Ancora Advisors / Ancora Holdings](https://ownershiptrace.com/13f/investors/101) | ANAPTYSBIO INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 337500.00 USD | 5000.000000 | Shares | buy | [Original filing](https://www.sec.gov/Archives/edgar/data/1446114/0001446114-26-000012-index.html) |
| [Tudor Investment](https://ownershiptrace.com/13f/investors/94675) | ANAPTYSBIO INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | [Original filing](https://www.sec.gov/Archives/edgar/data/923093/0000902664-26-003485-index.html) |

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

[How to read the data](https://ownershiptrace.com/docs#reading-the-data) · [Disclaimer](https://ownershiptrace.com/disclaimer)